Emergence of SARS-CoV-2 Variants and Impact on IVD Testing - POCTRN
Center news
Emergence of SARS-CoV-2 Variants and Impact on IVD Testing
Learn more about COVID-19 Variants and their impact on the testing environment
Speakers:
Richard Creager, PhD
Co-Founder & Partner, NaviDx LLC
Eric Lai, PhD
Ex-SVP at Takeda Pharmaceutical and Head of R&D at Gen-Probe Diagnostics
This webinar took place on March 23, 2021: